Clinical Trial Update: WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture [NA]

View source ↗

Summary

Clinical trial update for WallFlex Esophageal FC stents in refractory anastomotic esophageal strictures; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Stricture

Drugs mentioned

• WallFlex Esophageal Fully Covered (FC) Stent (WallFlex esophageal fully covered stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Refractory Anastomotic Esophageal Strictures | NA | Status: COMPLETED | Results posted: 2021-06-28